
    
      To analyze CosoptÂ® in terms of its effects on ocular perfusion pressure and comprehensive
      ocular blood flow and in relation to visual field progression and optic nerve structural
      changes in an ongoing 3 year prospective study involving 120 patients with open angle
      glaucoma.
    
  